Guselkumab Provides Relief For Patients Who Suffer With Psoriasis

Guselkumab Provides Relief For Patients Who Suffer With Psoriasis Overview A 52-week postmarketing surveillance study was launched to assess the safety and effectiveness of guselkumab, a human monoclonal antibody targeting the interleukin-23 subunit p19, in Japanese patients diagnosed with psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis, and erythrodermic psoriasis in real-world clinical

Brilliant Use Of Probiotic Medication To Treat Psoriasis

Brilliant Use Of Probiotic Medication To Treat Psoriasis Psoriasis, a chronic inflammatory skin disease, severely affects physical and mental health, often causing severe itching. Its prevalence is increasing, especially in developed countries, and is linked to genetics, immune disorders, infections, and environmental factors. Traditional treatments include topical corticosteroids and biologics, but

Piclidenoson In The Treatment Of Plaque Psoriasis

Piclidenoson In The Treatment Of Plaque Psoriasis Overview The study focused on evaluating the effectiveness and safety of piclidenoson (CF101), an orally bioavailable agonist for the A3 adenosine receptor (A3AR), in treating moderate-to-severe plaque psoriasis. The A3AR is known to be overexpressed in the skin and peripheral blood mononuclear cells of individuals

Guselkumab Provides Relief For Patients Who Suffer With Psoriasis